Akèy › Kansè Endomèt
Etid klinik pou Kansè Endomèt ap rekrite nan Etazini
168 etid pou Kansè Endomèt ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX68 etid
- New York City, NY52 etid
- Boston, MA50 etid
- Arlington, VA39 etid
- Nashville, TN38 etid
- Los Angeles, CA34 etid
- St. Louis, MO29 etid
- Philadelphia, PA28 etid
- San Antonio, TX27 etid
- Queens, NY25 etid
- Columbus, OH25 etid
- Chicago, IL25 etid
- Oklahoma City, OK25 etid
- Dallas, TX24 etid
- Portland, OR24 etid
- Pittsburgh, PA23 etid
- Detroit, MI21 etid
- Cleveland, OH20 etid
- Rochester, MN20 etid
- Edison, NJ19 etid
- Washington, DC18 etid
- Minneapolis, MN18 etid
- Grand Rapids, MI18 etid
- Orlando, FL17 etid
- Atlanta, GA17 etid
- Seattle, WA17 etid
- Baldwin Park, CA17 etid
- Durham, NC16 etid
- Miami, FL16 etid
- Birmingham, AL16 etid
- San Diego, CA16 etid
- Austin, TX15 etid
- Denver, CO15 etid
- Tampa, FL15 etid
- Sarasota, FL15 etid
- New Haven, CT14 etid
- Providence, RI14 etid
- Salt Lake City, UT14 etid
- Indianapolis, IN14 etid
- Aurora, CO14 etid
Pa eta
- Alabama19 etid
- Alaska4 etid
- Arizona22 etid
- Arkansas12 etid
- Ayiti3 etid
- Colorado30 etid
- Connecticut20 etid
- Delaware4 etid
- Distrik Columbia10 etid
- Florid65 etid
- Georgia24 etid
- Idaho4 etid
- Illinois38 etid
- Indiana19 etid
- Iowa10 etid
- Kalifòni73 etid
- Kansas5 etid
- Kentucky10 etid
- Lwizyàn15 etid
- Main7 etid
- Maryland22 etid
- Massachusetts53 etid
- Michigan43 etid
- Minnesota39 etid
- Mississippi5 etid
- Missouri31 etid
- Montana5 etid
- Nebraska10 etid
- Nevada8 etid
- New Jersey32 etid
- New Mexico13 etid
- New York69 etid
- North Carolina31 etid
- North Dakota6 etid
- Ohio50 etid
- Oklahoma28 etid
- Oregon27 etid
- Pennsylvania42 etid
- Rhode Island14 etid
- South Carolina9 etid
- South Dakota11 etid
- Tennessee41 etid
- Texas91 etid
- Utah25 etid
- Virginia51 etid
- Washington20 etid
- West Virginia4 etid
- Wisconsin24 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Tirzepatide in Obesity-Driven Endometrial Cancer
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Fanm · Mizajou Oct 2, 2026 · NCT07065552Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Ap rekriteFaz 2
Tout laj · Tout sèks · Mizajou Oct 2, 2026 · NCT05564377Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Fanm · Mizajou Oct 2, 2026 · NCT05950464The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750Distance-Based Exercise to Preserve Function and Prevent Disability
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07059884A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
Ap rekriteFaz 3
Laj 18 ak plis · Fanm · Mizajou Oct 2, 2026 · NCT07286331A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06270706Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Fanm · Mizajou Oct 2, 2026 · NCT07198074A Phase 1 Study of the Safety and Tolerability of CTX-10726
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07419841Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Ap rekriteFaz 2
Laj 18 a 72 · Tout sèks · Mizajou Oct 2, 2026 · NCT01174121A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06760819A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Ap rekriteFaz 1
Laj 19 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06586957A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06172478177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07189871The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07285044A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07814248Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Fanm · Mizajou Sep 29, 2026 · NCT05051722Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Sep 28, 2026 · NCT05112601Study of AVZO-021 in Patients With Advanced Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT05867251DESTINY-PANTUMOUR04
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06218914ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Sep 25, 2026 · NCT07270666Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Ap rekriteFaz 1/2
Laj 18 ak plis · Fanm · Mizajou Sep 25, 2026 · NCT03564340Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Sep 24, 2026 · NCT07594015A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Ap rekriteFaz 1/2
Laj 18 ak plis · Fanm · Mizajou Sep 24, 2026 · NCT04590326Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.